-
1دورية أكاديمية
عنوان ترانسليتريتد: Az orlistat szerepe az elhízás kezelésében.
المؤلفون: Paragh G; Debreceni Egyetem Orvos- és Egészségtudományi Centrum, Altalános Orvostudományi Kar, I. Belgyógyászati Klinika., Bajnok L
المصدر: Orvosi hetilap [Orv Hetil] 2005 Mar 13; Vol. 146 (11), pp. 493-8.
نوع المنشور: Journal Article; Review
بيانات الدورية: Publisher: Akademiai Kiado Country of Publication: Hungary NLM ID: 0376412 Publication Model: Print Cited Medium: Print ISSN: 0030-6002 (Print) Linking ISSN: 00306002 NLM ISO Abbreviation: Orv Hetil Subsets: MEDLINE
مواضيع طبية MeSH: Anti-Obesity Agents/*therapeutic use , Intestinal Absorption/*drug effects , Lactones/*therapeutic use , Lipase/*antagonists & inhibitors , Obesity/*drug therapy, Anti-Obesity Agents/adverse effects ; Humans ; Lactones/adverse effects ; Obesity/complications ; Obesity/therapy ; Orlistat ; Pancrelipase/antagonists & inhibitors
-
2دورية أكاديمية
عنوان ترانسليتريتد: BETA-PROPIOLACTONBAN STERILIZ'ALT KONZERVCSONT HASZN'ALATA 105 ESET KAPCS'AN.
المؤلفون: ZABORSZKY Z
المصدر: Orvosi hetilap [Orv Hetil] 1963 Nov 17; Vol. 104, pp. 2183-4.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Akademiai Kiado Country of Publication: Hungary NLM ID: 0376412 Publication Model: Print Cited Medium: Print ISSN: 0030-6002 (Print) Linking ISSN: 00306002 NLM ISO Abbreviation: Orv Hetil Subsets: OLDMEDLINE
مواضيع طبية MeSH: Anti-Infective Agents* , Anti-Infective Agents, Local* , Bone Transplantation* , Lactones* , Propiolactone* , Sterilization* , Tissue Banks*, Humans
-
3دورية أكاديمية
عنوان ترانسليتريتد: Az elhízás gyógyszeres kezelése: múlt, jelen, jövő
المؤلفون: Simonyi G; Pest Megyei Flór Ferenc Kórház, Kardiometabolikus Centrum V. Belgyógyászat-Lipidológiai Osztály, Regionális Zsíranyagcsere-központ és Hypertonia Decentrum, Budapest. bmbel3@gmail.com, Pados G, Medvegy M, Bedros JR
المصدر: Orvosi hetilap [Orv Hetil] 2012 Mar 11; Vol. 153 (10), pp. 363-73.
نوع المنشور: Journal Article; Review
بيانات الدورية: Publisher: Akademiai Kiado Country of Publication: Hungary NLM ID: 0376412 Publication Model: Print Cited Medium: Print ISSN: 0030-6002 (Print) Linking ISSN: 00306002 NLM ISO Abbreviation: Orv Hetil Subsets: MEDLINE
مواضيع طبية MeSH: Anti-Obesity Agents/*therapeutic use , Obesity/*drug therapy, Amides/therapeutic use ; Anti-Obesity Agents/administration & dosage ; Anti-Obesity Agents/adverse effects ; Anti-Obesity Agents/pharmacology ; Anticonvulsants/therapeutic use ; Antidepressive Agents/therapeutic use ; Basal Metabolism/drug effects ; Benzazepines/therapeutic use ; Benzoxazines/therapeutic use ; Body Mass Index ; Bridged Bicyclo Compounds, Heterocyclic/therapeutic use ; Ciliary Neurotrophic Factor/therapeutic use ; Clinical Trials as Topic ; Combined Modality Therapy ; Cyclobutanes/therapeutic use ; Dexfenfluramine/therapeutic use ; Fatty Acids/therapeutic use ; Female ; Fenfluramine/therapeutic use ; Glucagon-Like Peptide 1/analogs & derivatives ; Glucagon-Like Peptide 1/pharmacology ; Human Growth Hormone/therapeutic use ; Humans ; Intestinal Absorption/drug effects ; Lactones/therapeutic use ; Leptin/therapeutic use ; Life Style ; Liraglutide ; Male ; Norepinephrine/analogs & derivatives ; Obesity/prevention & control ; Obesity/therapy ; Obesity, Morbid/drug therapy ; Orlistat ; Piperidines/therapeutic use ; Pyrazoles/therapeutic use ; Pyridines/therapeutic use ; Receptor, Melanocortin, Type 4/antagonists & inhibitors ; Rimonabant ; Satiation/drug effects ; Serotonin/analogs & derivatives ; Sodium-Glucose Transport Proteins/antagonists & inhibitors ; Sucrose/analogs & derivatives ; Sucrose/therapeutic use ; Thyroid Hormones/therapeutic use
-
4دورية أكاديمية
عنوان ترانسليتريتد: Az elhízás korszerû kezelése.
المؤلفون: Pados G; Szent Imre Kórház, Kardiometabolikus Centrum, Lipidrészleg, Budapest, Tétényi út 12-16. 1115. lipidreszleg@gmail.com
المصدر: Orvosi hetilap [Orv Hetil] 2010 Mar 21; Vol. 151 (12), pp. 501-4.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Akademiai Kiado Country of Publication: Hungary NLM ID: 0376412 Publication Model: Print Cited Medium: Print ISSN: 0030-6002 (Print) Linking ISSN: 00306002 NLM ISO Abbreviation: Orv Hetil Subsets: MEDLINE
مواضيع طبية MeSH: Bariatric Surgery* , Behavior Therapy* , Caloric Restriction* , Exercise*, Anti-Obesity Agents/*therapeutic use , Dietary Carbohydrates/*administration & dosage , Dietary Proteins/*administration & dosage , Obesity/*therapy, Body Mass Index ; Clinical Trials as Topic ; Consensus Development Conferences as Topic ; Diet Records ; Dietary Fats/administration & dosage ; Female ; Humans ; Lactones/therapeutic use ; Male ; Metabolic Syndrome/therapy ; Obesity/diagnosis ; Obesity/diet therapy ; Obesity/drug therapy ; Obesity/surgery ; Orlistat ; Physical Exertion ; Practice Guidelines as Topic ; Time Factors ; Waist Circumference ; Weight Loss
-
5دورية أكاديمية
عنوان ترانسليتريتد: Megelózhetó-e a 2-es típusú diabetes mellitus?
المؤلفون: Jermendy G; Bajcsy-Zsilinszky Kórház, III. Belgyógyászati Osztály, Budapest. gyjermendy@mail.datanet.hu
المصدر: Orvosi hetilap [Orv Hetil] 2003 Sep 28; Vol. 144 (39), pp. 1909-17.
نوع المنشور: Journal Article; Review
بيانات الدورية: Publisher: Akademiai Kiado Country of Publication: Hungary NLM ID: 0376412 Publication Model: Print Cited Medium: Print ISSN: 0030-6002 (Print) Linking ISSN: 00306002 NLM ISO Abbreviation: Orv Hetil Subsets: MEDLINE
مواضيع طبية MeSH: Exercise* , Life Style*, Diabetes Mellitus, Type 2/*prevention & control , Hypoglycemic Agents/*therapeutic use , Primary Prevention/*methods, Acarbose/therapeutic use ; Angiotensin-Converting Enzyme Inhibitors/therapeutic use ; Anti-Obesity Agents/therapeutic use ; Antihypertensive Agents/therapeutic use ; Clinical Trials as Topic ; Diabetes Mellitus, Type 2/epidemiology ; Diabetes Mellitus, Type 2/etiology ; Global Health ; Humans ; Hypolipidemic Agents/therapeutic use ; Incidence ; Lactones/therapeutic use ; Metabolic Syndrome/complications ; Metformin/therapeutic use ; Orlistat ; Prevalence ; Risk Factors
-
6دورية أكاديمية
عنوان ترانسليتريتد: Obes betegek lipidprofiljának és paraoxonáz aktivitásának változása orlistat kezelést követóen.
المؤلفون: Audikovszky M; Fóvárosi Szent Imre Kórház IV, sz. Belgyógyászati Osztály., Pados G, Seres I, Harangi M, Fülöp P, Katona E, Winkler G, Paragh G
المصدر: Orvosi hetilap [Orv Hetil] 2001 Dec 16; Vol. 142 (50), pp. 2779-83.
نوع المنشور: Clinical Trial; Controlled Clinical Trial; Journal Article; Multicenter Study
بيانات الدورية: Publisher: Akademiai Kiado Country of Publication: Hungary NLM ID: 0376412 Publication Model: Print Cited Medium: Print ISSN: 0030-6002 (Print) Linking ISSN: 00306002 NLM ISO Abbreviation: Orv Hetil Subsets: MEDLINE
مواضيع طبية MeSH: Diet, Reducing*, Anti-Obesity Agents/*therapeutic use , Enzyme Inhibitors/*pharmacology , Esterases/*metabolism , Lactones/*therapeutic use , Lipase/*antagonists & inhibitors , Lipids/*blood , Obesity/*drug therapy , Obesity/*metabolism, Abdomen ; Adult ; Aged ; Aryldialkylphosphatase ; Body Mass Index ; Body Weight ; Cholesterol/blood ; Female ; Humans ; Male ; Middle Aged ; Obesity/diet therapy ; Obesity/enzymology ; Orlistat ; Time Factors ; Treatment Outcome ; Triglycerides/blood